证券记录 · 已归档季度
OGN
Organon & Co. · Healthcare · Drug Manufacturers - General
19被追踪持有人
+2Δ持有人
102.90M持有股份
$1.10B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +11.8% ·
股份流向 -3.0% ·
净新建仓位 +5.3%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 29.20K | $401,493 | n/a | n/a |
| Q2 2026 | 110 | -5 | 127.45M | $1.69B | +9 | −15 |
| Q1 2026 | 119 | +3 | 138.29M | $828.86M | +8 | −6 |
| Q4 2025 | 116 | 0 | 159.06M | $1.14B | +2 | −1 |
| Q3 2025 | 19 | +2 | 102.90M | $1.10B | +2 | −1 |
| Q2 2025 | 15 | +2 | 101.45M | $982.02M | +3 | −1 |
| Q1 2025 | 10 | -1 | 22.51M | $334.60M | n/a | −1 |
| Q4 2024 | 11 | -3 | 17.81M | $265.62M | n/a | −3 |
| Q3 2024 | 13 | +3 | 12.85M | $245.79M | +4 | −1 |
| Q2 2024 | 10 | n/a | 11.89M | $246.22M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 35.93M | +11.3% | $383.72M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 30.86M | -0.9% | $329.57M | 0.0% | ▼ Trim | 2 | SEC ↗ ×15 |
| 3 | State Street Global Advisors ✦ (被动) | 9.34M | -1.9% | $99.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 4.82M | +9.6% | $51.44M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 4.53M | -50.2% | $48.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 4.36M | n/a | $46.54M | 0.0% | n/c | 1 | SEC ↗ ×11 |
| 7 | AQR Capital Management ✦ | 4.18M | +28.3% | $43.64M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 8 | Gotham Asset Management ✦ | 3.71M | +37.2% | $39.66M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 9 | Goldman Sachs Group ✦ | 1.66M | n/a | $17.69M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 668.69K | +254.9% | $7.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 641.36K | +310.1% | $6.85M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 640.69K | n/a | $6.84M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 13 | D. E. Shaw & Co. ✦ | 490.86K | 新增 | $5.24M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 416.24K | -92.4% | $4.45M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Fidelity (FMR) ✦ | 238.95K | -74.2% | $2.55M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 16 | T. Rowe Price ✦ | 207.85K | +7.1% | $2.22M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Wellington Management ✦ | 134.43K | 新增 | $1.44M | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 74.84K | -5.5% | $799,323 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 11.63K | -5.4% | $124,208 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $5.24M | 0.0% |
| Wellington Management | $1.44M | 0.0% |
已清仓
| Norges Bank | $19.78M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 604 持有人, 199.08M 股份, $1.18B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Aug 14
SC 13G: Pentwater Capital Management LP
Jul 31
SC 13G/A: VANGUARD PORTFOLIO MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据